ÌÇÐÄÆƽâ°æ

In the fiscal year of 2021, Siemens generated over billion euros in revenue from its Mobility segment, which comprises all Siemens businesses in passenger and freight transportation. The German engineering and electronics company's best-performing segment for the financial year was its Healthineers segment, with a revenue of almost ***billion euros. The Digital Industries segment, which is the backbone of Siemens’ portfolio of industrial automation products and solutions, generated almost ***billion euros in revenue.

Leader of industrial automation

Due to Siemens being one of the largest conglomerates in the world with a significant pool of resources, it afford to finance research of various automation technologies that would be too resource-demanding for smaller companies. Just in 2020, Siemens spent around ****billion euros on research and development. Although most of the industrial automation market is dominated by big conglomerates, there is still room for smaller companies and start-ups to thrive. As more industries want to automate, the growing market offers opportunities for companies that can come up with innovate products and solutions.

Digitalization of vaccine development

In 2021, Siemens started collaborating with a pharmaceutical company GSK to digitalize the process of vaccine development and production process. Working together with ATOS, a consulting company in the field of IT, Siemens will use data from a real plant in which vaccines are developed and produced to create its digital twin. In this digital twin, simulations of vaccine development and production will be run, saving GSK hours of real-life work and speeding up the development and production of vaccines.
GSK is currently collaborating with the French pharmaceuticals company Sanofi to develop a Covid-19 vaccine. While still in a phase three clinical trial as of May 2021, the companies have received more than ****million orders for the vaccine.